Kymera Therapeutics Inc (KYMR)
43.51
-0.54
(-1.23%)
USD |
NASDAQ |
Nov 21, 16:00
43.56
+0.05
(+0.11%)
After-Hours: 20:00
Kymera Therapeutics Market Cap: 2.818B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.818B |
| November 20, 2024 | 2.853B |
| November 19, 2024 | 2.775B |
| November 18, 2024 | 2.747B |
| November 15, 2024 | 2.718B |
| November 14, 2024 | 2.976B |
| November 13, 2024 | 3.150B |
| November 12, 2024 | 3.238B |
| November 11, 2024 | 3.357B |
| November 08, 2024 | 3.300B |
| November 07, 2024 | 3.229B |
| November 06, 2024 | 3.205B |
| November 05, 2024 | 3.089B |
| November 04, 2024 | 3.049B |
| November 01, 2024 | 3.010B |
| October 31, 2024 | 2.990B |
| October 30, 2024 | 3.087B |
| October 29, 2024 | 3.140B |
| October 28, 2024 | 3.179B |
| October 25, 2024 | 3.108B |
| October 24, 2024 | 3.155B |
| October 23, 2024 | 3.157B |
| October 22, 2024 | 3.132B |
| October 21, 2024 | 3.015B |
| October 18, 2024 | 3.005B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.995B |
| October 16, 2024 | 3.174B |
| October 15, 2024 | 2.901B |
| October 14, 2024 | 2.982B |
| October 11, 2024 | 2.915B |
| October 10, 2024 | 2.800B |
| October 09, 2024 | 2.806B |
| October 08, 2024 | 2.787B |
| October 07, 2024 | 2.733B |
| October 04, 2024 | 2.788B |
| October 03, 2024 | 2.811B |
| October 02, 2024 | 2.914B |
| October 01, 2024 | 3.015B |
| September 30, 2024 | 3.065B |
| September 27, 2024 | 3.145B |
| September 26, 2024 | 3.195B |
| September 25, 2024 | 3.354B |
| September 24, 2024 | 3.384B |
| September 23, 2024 | 3.228B |
| September 20, 2024 | 3.216B |
| September 19, 2024 | 3.167B |
| September 18, 2024 | 2.999B |
| September 17, 2024 | 3.055B |
| September 16, 2024 | 3.131B |
| September 13, 2024 | 2.976B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
608.70M
Minimum
Oct 27 2023
3.905B
Maximum
Dec 28 2020
1.992B
Average
1.926B
Median
Jan 20 2023
Market Cap Benchmarks
| Amgen Inc | 155.83B |
| Voyager Therapeutics Inc | 296.62M |
| Denali Therapeutics Inc | 3.486B |
| Vir Biotechnology Inc | 957.15M |
| Avidity Biosciences Inc | 5.078B |
Market Cap Related Metrics
| PS Ratio | 34.59 |
| Price to Book Value | 3.156 |
| Price | 43.51 |
| Earnings Yield | -5.38% |